Top Healthcare stocks:
Healthcare shares were mixed in pre-market trade on Monday.
In healthcare stocks news, Merck (
) said it plans to buy Idenix (
) in a $3.85 billion deal.
IDIX shares were up 232.2% at $24.02, well past their 52-week
high of $9.32. MRK was down 0.6% at $57.50 in pre-market trade with
a 52-week range of $44.62 to $59.84.
And, Cancer Genetics, Inc. (
) has been selected by AstraZeneca to provide biomarker-based
diagnostic testing for cancer in Central America and the Caribbean.
The companies will work in close conjunction on exploring expansion
opportunities into additional geographic territories, further
oncology categories, and into select oncology trials.
The relationship is expected to concentrate on multiple cancer
categories, with lung cancer being an initial area of focus.
Shares of CGXI were up more than 6% in
with a 52-week range of $7.00 - $23.25.
Finally Natus Medical (
) approved a stock repurchase program authorizing the repurchase of
up to $10 million of the company's common stock.
There is no set expiration date for the program. The primary
objective of the share repurchase program is to offset the impact
of dilution from issuances relating to employee equity grants and
the Company's employee stock purchase program.
Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.